H
Haiyan Zhan
Researcher at Wuhan Jinyintan Hospital
Publications - 3
Citations - 4293
Haiyan Zhan is an academic researcher from Wuhan Jinyintan Hospital. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 1, co-authored 1 publications receiving 3577 citations.
Papers
More filters
Journal ArticleDOI
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao,Yeming Wang,Danning Wen,Wen Liu,Jingli Wang,Guohui Fan,Lianguo Ruan,Bin Song,Yanping Cai,Ming Wei,Xingwang Li,Jia'an Xia,Nanshan Chen,Jie Xiang,Ting Yu,Tao Bai,Xuelei Xie,Li Zhang,Caihong Li,Ye Yuan,Hua Chen,Huadong Li,Hanping Huang,Shengjing Tu,Fengyun Gong,Ying Liu,Yuan Wei,Chongya Dong,Fei Zhou,Xiaoying Gu,Jiuyang Xu,Zhibo Liu,Yi Zhang,Li Hui,Lianhan Shang,Ke Wang,Kunxia Li,Xia Zhou,Xuan Dong,Zhaohui Qu,Sixia Lu,Xujuan Hu,Shunan Ruan,Shanshan Luo,Jing Wu,Lu Peng,Fang Cheng,Lihong Pan,Jun Zou,Chunmin Jia,Juan Wang,Xia Liu,Shuzhen Wang,Xudong Wu,Qin Ge,Jing He,Haiyan Zhan,Fang Qiu,Li Guo,Chaolin Huang,Thomas Jaki,Frederick G. Hayden,Peter Horby,Dingyu Zhang,Chen Wang +64 more
TL;DR: In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit.
Journal ArticleDOI
Incidence and non-genetic risk factors of irinotecan-induced severe neutropenia in Chinese adult inpatients
Shuxiao Zhang,Jing-Xiang Yang,Haiyan Zhan,Boning Yang,Peipei Rong,Yi Luo,Cai Shi,Ying Chen,Jian Yang +8 more
TL;DR: In this article , a retrospective analysis of patients who received irinotecan-based chemotherapy from May 2014 to May 2019 in Renmin Hospital of Wuhan University was conducted.
Journal ArticleDOI
Drug-induced liver injury in COVID-19 patients during hospitalization
TL;DR: Wang et al. as discussed by the authors performed a single-center retrospective analysis of confirmed severe acute respiratory syndrome coronavirus 2 infected patients in the hospital from January 2020 to March 2020, and used univariate and multivariate logistic regression analysis to assess the risk factors associated with liver test abnormality or liver injury.